Global

News Releases

This section features all recent CSL Behring news releases. Click the tabs to select releases in your area of interest. Click Resources to find additional background material on CSL Behring.

All Releases
Corporate
Immunology
Bleeding Disorders
Hereditary Angioedema (HAE)
Pulmonary
Fluid Management
Resources

All Releases

19 September 2017 CSL Behring Will Help Transform Biotech Education and Research with $4.92 Million Gift to Penn State

Penn State today announced that CSL Behring has committed $4.92 million to Penn State over the next six years to create the multidisciplinary Center of Excellence in Biotechnology, and to revitalize the Shared Fermentation Facility.

> Read More
14 September 2017 CSL Behring Joins Together With Conference Attendees to Make Donation to IPOPI

Immunoglobulin Leader Donates €15,000 to IPOPI International Patient Organisation to Support Primary Immunodeficiency Awareness Initiatives.

> Read More
14 September 2017 CSL Behring Announces FDA Approval of Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults

Privigen is now approved for US adult chronic inflammatory demyelinating polyneuropathy (CIDP) patients.

> Read More
07 September 2017 CSL Behring Presents New Alpha 1 Antitrypsin Deficiency Treatment Data at Global ERS Congress

CSL Behring presents data and hosts symposium on real life experiences with Alpha-1.

> Read More
06 September 2017 CSL Behring Joins Together With Others Around the World—Sponsoring the 2017 Meeting of the European Society for Immunodeficiencies (ESID)

Immunoglobulins leader, CSL Behring, sponsors ESID meeting and hosts symposium on new developments in secondary antibody deficiency.

> Read More
Page 1 of 7 Next | Last

Share
LinkedIn Twitter Facebook Google+